Vorasidenib and grading of IDH mutant astrocytoma

from Neuro-Oncology: The Podcast · host Dr. Ankush Bhatia, Dr. Matthias Preusser, DR. Iyad Alnahhas

Description: Dr. Ankush Bhatia interviews Dr. Matthias Preusser about the recent letter in Neuro-Oncology, entitled: "What is an isocitrate dehydrogenase-mutated central nervous system World Health Organization grade 2 glioma, or who should receive vorasidenib?", published in July 2023.

Episode metadata supplied by the publisher feed · Published Oct 27, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

Vorasidenib and grading of IDH mutant astrocytoma

0:00 24:11

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Neuro-Oncology: The Podcast?

This episode is 24 minutes long.

When was this Neuro-Oncology: The Podcast episode published?

This episode was published on October 27, 2023.

Can I download this Neuro-Oncology: The Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!